NO20000851L - Behandling av Staphylococcus aureus - Google Patents

Behandling av Staphylococcus aureus

Info

Publication number
NO20000851L
NO20000851L NO20000851A NO20000851A NO20000851L NO 20000851 L NO20000851 L NO 20000851L NO 20000851 A NO20000851 A NO 20000851A NO 20000851 A NO20000851 A NO 20000851A NO 20000851 L NO20000851 L NO 20000851L
Authority
NO
Norway
Prior art keywords
staphylococcus aureus
treatment
strains
strain
directed
Prior art date
Application number
NO20000851A
Other languages
English (en)
Other versions
NO327042B1 (no
NO20000851D0 (no
Inventor
Thalia Ioanna Nicas
David Albert Preston
Michael Lee Zeckel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20000851D0 publication Critical patent/NO20000851D0/no
Publication of NO20000851L publication Critical patent/NO20000851L/no
Publication of NO327042B1 publication Critical patent/NO327042B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Den foreliggende oppfinnelsen er rettet mot fremgangsmåter for behandling av infeksjoner forårsaket av Staphylococcus aureus med redusert glykopeptidsensitivitet. Oppfinnelsen blir foretrukket praktisert med stammer av Staphylococcus aureus som er methicillin-resistent, slik som Mu50-stammen.
NO20000851A 1997-08-22 2000-02-21 Anvendelse av en effektiv mengde av NDISACC-(4-(4-klorfenyl)benzyl)A82846B for fremstilling av et medikament for behandling av en infeksjonssykdom. NO327042B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5671297P 1997-08-22 1997-08-22
PCT/US1998/017138 WO1999010006A1 (en) 1997-08-22 1998-08-18 Therapy for staphylococcus aureus

Publications (3)

Publication Number Publication Date
NO20000851D0 NO20000851D0 (no) 2000-02-21
NO20000851L true NO20000851L (no) 2000-02-21
NO327042B1 NO327042B1 (no) 2009-04-06

Family

ID=22006150

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000851A NO327042B1 (no) 1997-08-22 2000-02-21 Anvendelse av en effektiv mengde av NDISACC-(4-(4-klorfenyl)benzyl)A82846B for fremstilling av et medikament for behandling av en infeksjonssykdom.

Country Status (23)

Country Link
US (1) US5994297A (no)
EP (1) EP0897725B1 (no)
JP (1) JP2001513573A (no)
KR (1) KR100589548B1 (no)
CN (1) CN1276728A (no)
AT (1) ATE278413T1 (no)
AU (1) AU747418B2 (no)
BR (1) BR9811917A (no)
CA (1) CA2301589A1 (no)
CZ (1) CZ299098B6 (no)
DE (1) DE69826795T2 (no)
DK (1) DK0897725T3 (no)
EA (1) EA002602B1 (no)
ES (1) ES2229454T3 (no)
HU (1) HU226593B1 (no)
ID (1) ID24908A (no)
IL (2) IL134597A0 (no)
NO (1) NO327042B1 (no)
NZ (1) NZ502762A (no)
PT (1) PT897725E (no)
TR (1) TR200000475T2 (no)
UA (1) UA59410C2 (no)
WO (1) WO1999010006A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2337575T3 (pl) * 2008-08-30 2016-09-30 Sposoby leczenia z użyciem pojedynczych dawek orytawancyny
CN101928331B (zh) * 2009-06-26 2014-05-28 上海来益生物药物研究开发中心有限责任公司 一种化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW457248B (en) * 1994-01-28 2001-10-01 Lilly Co Eli Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
EP0897725A2 (en) 1999-02-24
IL134597A0 (en) 2001-04-30
CN1276728A (zh) 2000-12-13
NZ502762A (en) 2001-10-26
DE69826795D1 (de) 2004-11-11
EP0897725A3 (en) 2000-02-09
NO327042B1 (no) 2009-04-06
PT897725E (pt) 2004-12-31
US5994297A (en) 1999-11-30
AU8913798A (en) 1999-03-16
CZ2000619A3 (en) 2001-05-16
NO20000851D0 (no) 2000-02-21
HUP0002920A3 (en) 2001-12-28
IL134597A (en) 2007-09-20
WO1999010006A1 (en) 1999-03-04
ATE278413T1 (de) 2004-10-15
DE69826795T2 (de) 2005-10-06
JP2001513573A (ja) 2001-09-04
ID24908A (id) 2000-08-31
BR9811917A (pt) 2000-08-15
KR100589548B1 (ko) 2006-06-15
UA59410C2 (uk) 2003-09-15
ES2229454T3 (es) 2005-04-16
KR20010023108A (ko) 2001-03-26
HU226593B1 (en) 2009-04-28
EA200000250A1 (ru) 2000-08-28
TR200000475T2 (tr) 2000-08-21
EP0897725B1 (en) 2004-10-06
CZ299098B6 (cs) 2008-04-23
CA2301589A1 (en) 1999-03-04
EA002602B1 (ru) 2002-06-27
HUP0002920A2 (hu) 2001-01-29
DK0897725T3 (da) 2004-12-13
AU747418B2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ES2119185T3 (es) Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad.
AP9200410A0 (en) Retroviral protease inhibitors.
SE7611103L (sv) Forfarande for framstellning av 2-azetidinonforeningar
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
MA55981B1 (fr) Antibiotiques macrocycliques à large spectre
ATE299871T1 (de) Neue zyklische depsipeptid pf1022 derivate
DE69928384D1 (de) Behandlung und nachweis von staphylokokkeninfektionen
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
TNSN04035A1 (fr) Azithromycine en dose unique
ATE199321T1 (de) Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen.
NO20044548L (no) Fremgangsmate for fremstilling av 6-alkaliden-penemderivater
EA200500353A1 (ru) Производные линкомицина, обладающие антибактериальной активностью
NO20000851L (no) Behandling av Staphylococcus aureus
DE69828443D1 (de) Säugetierabkömmliche peptide zur behandlung von mikrobiellen infektionen
TR200101841T2 (tr) Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları
NO20010140L (no) Kjemotakse-inhiberende protein av Staphylococcus (CHIPS) og dets anvendelse
DE60029463D1 (de) Behandlung von dyskinesie
MX2021011469A (es) Combinacion de lisina(s) y antibiotico(s) para tratar o prevenir endocarditis infecciosa debida a bacterias gram-positivas.
EA200300725A1 (ru) Соединение азола в качестве противогрибковых средств
MA59341A1 (fr) Analogues de rifamycine et conjugués anticorps-médicament de ceux-ci
ATE212839T1 (de) Hämoregulatorische verbindungen
TR199902914T2 (xx) �zole sistolik hipertansiyonu tedavi y�ntemi.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees